Fig. 1From: Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOWPatient disposition during the study. BCVA best-corrected visual acuity, FAS full analysis set, M0 Month zeroBack to article page